GR3036707T3 - Benzoxazepine compounds, their production and use as lipid lowering agents - Google Patents
Benzoxazepine compounds, their production and use as lipid lowering agentsInfo
- Publication number
- GR3036707T3 GR3036707T3 GR20010401564T GR20010401564T GR3036707T3 GR 3036707 T3 GR3036707 T3 GR 3036707T3 GR 20010401564 T GR20010401564 T GR 20010401564T GR 20010401564 T GR20010401564 T GR 20010401564T GR 3036707 T3 GR3036707 T3 GR 3036707T3
- Authority
- GR
- Greece
- Prior art keywords
- production
- lowering agents
- lipid lowering
- benzoxazepine compounds
- benzoxazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23545795 | 1995-09-13 | ||
| PCT/JP1996/002596 WO1997010224A1 (en) | 1995-09-13 | 1996-09-12 | Benzoxazepine compounds, their production and use as lipid lowering agents |
| ZA972134A ZA972134B (en) | 1995-09-13 | 1997-03-12 | Benzoxazepine compounds their production and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3036707T3 true GR3036707T3 (en) | 2001-12-31 |
Family
ID=26532138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20010401564T GR3036707T3 (en) | 1995-09-13 | 2001-09-26 | Benzoxazepine compounds, their production and use as lipid lowering agents |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0862562B1 (el) |
| CN (1) | CN1072649C (el) |
| AU (1) | AU6944296A (el) |
| GR (1) | GR3036707T3 (el) |
| WO (1) | WO1997010224A1 (el) |
| ZA (1) | ZA972134B (el) |
Families Citing this family (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965553A (en) * | 1996-06-20 | 1999-10-12 | Pfizer Inc. | Squalene synthetase inhibitors |
| AU2401697A (en) * | 1996-06-20 | 1998-01-07 | Pfizer Inc. | 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors |
| WO1998047882A1 (en) | 1997-04-21 | 1998-10-29 | Takeda Chemical Industries, Ltd. | 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists |
| JP4204657B2 (ja) * | 1997-12-05 | 2009-01-07 | 有限会社ケムフィズ | 糖尿病の予防・治療剤 |
| AU1648001A (en) * | 1999-11-30 | 2001-06-12 | Takeda Chemical Industries Ltd. | Process for production of optically active benzhydrols |
| CA2413429A1 (en) * | 2000-06-23 | 2001-12-27 | Takeda Chemical Industries, Ltd. | Benzoxazepinones and their use as squalene synthase inhibitors |
| KR20030048465A (ko) * | 2000-11-09 | 2003-06-19 | 다케다 야쿠힌 고교 가부시키가이샤 | 고밀도 지질단백질-콜레스테롤 상승제 |
| US20040077689A1 (en) | 2001-04-25 | 2004-04-22 | Yasuo Sugiyama | Abc expression promoters |
| US20040204500A1 (en) * | 2001-06-28 | 2004-10-14 | Yasuo Sugiyama | Preventives/remedies for organ functional disorders and organ dysfunction |
| AU2003277576A1 (en) | 2002-11-08 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
| EP1600166A4 (en) * | 2003-01-17 | 2008-02-27 | Takeda Pharmaceutical | SKELETAL MUSCLE PROTECTIVE AGENT |
| EP1591120A4 (en) * | 2003-01-28 | 2009-06-10 | Takeda Chemical Industries Ltd | RECEPTOR AGONISTS |
| US20070129348A1 (en) * | 2003-04-18 | 2007-06-07 | Fumio Itoh | Receptor antagonist |
| AU2004285354B2 (en) | 2003-10-31 | 2009-09-17 | Takeda Pharmaceutical Company Limited | Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
| JP4859665B2 (ja) | 2004-03-30 | 2012-01-25 | 武田薬品工業株式会社 | アルコキシフェニルプロパン酸誘導体 |
| CN101035520A (zh) * | 2004-08-09 | 2007-09-12 | 武田药品工业株式会社 | Crp降低剂 |
| EP2308839B1 (en) | 2005-04-20 | 2017-03-01 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds |
| EP1876179B1 (en) | 2005-04-28 | 2015-03-25 | Takeda Pharmaceutical Company Limited | Thienopyrimidone compounds |
| AR054368A1 (es) * | 2005-06-01 | 2007-06-20 | Takeda Pharmaceutical | Metodo para tratar hiperlipidemia |
| ES2434072T3 (es) | 2005-06-09 | 2013-12-13 | Norgine Bv | Preparación sólida de 2-hexadeciloxi-6-metil-4H-3,1-benzoxacin-4-ona |
| MY152185A (en) | 2005-06-10 | 2014-08-29 | Novartis Ag | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| PE20070458A1 (es) | 2005-09-14 | 2007-07-05 | Takeda Pharmaceutical | Composicion farmaceutica que comprende 2-[[6-(3r)-3-amino-1-piperidinil]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-benzonitrilo como inhibidor de dipeptidil peptidasa |
| WO2007074884A1 (ja) | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | 糖尿病治療剤 |
| JPWO2007119833A1 (ja) | 2006-04-14 | 2009-08-27 | 武田薬品工業株式会社 | 含窒素複素環化合物 |
| RS52307B (en) | 2006-06-27 | 2012-12-31 | Takeda Pharmaceutical Company Limited | CONDENSED CYCLIC UNITS |
| US20100029619A1 (en) | 2006-08-04 | 2010-02-04 | Takeda Pharmaceutical Company Limted | Fused heterocyclic compound |
| US8492405B2 (en) | 2006-10-18 | 2013-07-23 | Takeda Pharmaceutical Company Limited | Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity |
| KR101444486B1 (ko) | 2006-10-19 | 2014-09-24 | 다케다 야쿠힌 고교 가부시키가이샤 | 인돌 화합물 |
| EP2128163A1 (en) | 2007-01-25 | 2009-12-02 | Takeda Pharmaceutical Company Limited | Spiro-ring compound |
| JPWO2008102749A1 (ja) | 2007-02-20 | 2010-05-27 | 武田薬品工業株式会社 | 複素環化合物 |
| US8318746B2 (en) | 2007-04-27 | 2012-11-27 | Takeda Pharmaceutical Company Limited | Nitrogen-containing five-membered heterocyclic compound |
| TW200914006A (en) | 2007-07-12 | 2009-04-01 | Takeda Pharmaceutical | Coated preparation |
| CN101801351B (zh) | 2007-07-19 | 2012-12-12 | 武田药品工业株式会社 | 包含阿格列汀和盐酸二甲双胍的固体制剂 |
| JP5374377B2 (ja) | 2007-10-18 | 2013-12-25 | 武田薬品工業株式会社 | 複素環化合物 |
| WO2009057784A1 (ja) | 2007-11-01 | 2009-05-07 | Takeda Pharmaceutical Company Limited | 複素環化合物 |
| JP5421126B2 (ja) | 2008-01-10 | 2014-02-19 | 武田薬品工業株式会社 | カプセル製剤 |
| EP2261213A1 (en) | 2008-04-01 | 2010-12-15 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| EP2266983B1 (en) | 2008-04-16 | 2013-06-05 | Takeda Pharmaceutical Company Limited | Nitrogenated 5-membered heterocyclic compound |
| US20110136788A1 (en) | 2008-08-07 | 2011-06-09 | Minoru Maruyama | Therapeutic agent for irritable bowel syndrome |
| UY32126A (es) | 2008-09-25 | 2010-04-30 | Takeda Pharmaceutical | Composición farmacéutica sólida |
| EP2351743A4 (en) | 2008-10-27 | 2012-05-09 | Takeda Pharmaceutical | BICYCLIC CONNECTION |
| WO2010076884A1 (ja) | 2008-12-29 | 2010-07-08 | 武田薬品工業株式会社 | 新規縮合環化合物およびその用途 |
| JP2010254623A (ja) | 2009-04-24 | 2010-11-11 | Takeda Chem Ind Ltd | ベンゾオキサジノン化合物の結晶 |
| EP2440541A1 (en) | 2009-06-09 | 2012-04-18 | Takeda Pharmaceutical Company Limited | Novel fused cyclic compound and use thereof |
| CN102548556A (zh) | 2009-07-28 | 2012-07-04 | 武田药品工业株式会社 | 片剂 |
| WO2011041293A1 (en) | 2009-09-30 | 2011-04-07 | Takeda Pharmaceutical Company Limited | Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors |
| WO2011097079A1 (en) | 2010-02-03 | 2011-08-11 | Takeda Pharmaceutical Company Limited | Apoptosis signal-regulating kinase 1 inhibitors |
| NZ603777A (en) | 2010-04-27 | 2013-08-30 | Takeda Pharmaceutical | Bicyclic compound derivatives and their use as acc inhibitors. |
| PE20130283A1 (es) | 2010-06-16 | 2013-03-25 | Takeda Pharmaceutical | Cristal de compuesto de amida |
| EP2617726A4 (en) | 2010-09-17 | 2014-05-14 | Takeda Pharmaceutical | DIABETES THERAPEUTIC |
| JP2013209295A (ja) | 2010-10-13 | 2013-10-10 | Takeda Chem Ind Ltd | ペプチド誘導体 |
| JP5824517B2 (ja) | 2010-11-30 | 2015-11-25 | 武田薬品工業株式会社 | 二環性化合物 |
| US8952185B2 (en) | 2011-02-17 | 2015-02-10 | Takeda Pharmaceutical Company Limited | Production method of optically active dihydrobenzofuran derivative |
| EP2772485A4 (en) | 2011-10-24 | 2015-06-10 | Takeda Pharmaceutical | BICYCLIC CONNECTION |
| JP6129850B2 (ja) | 2012-01-12 | 2017-05-17 | 武田薬品工業株式会社 | Ｍｃｈ受容体拮抗剤としてのベンゾイミダゾール誘導体 |
| JP6095580B2 (ja) | 2012-02-13 | 2017-03-15 | 武田薬品工業株式会社 | 芳香環化合物 |
| EP2816032A4 (en) | 2012-02-13 | 2015-09-30 | Takeda Pharmaceutical | AROMATIC CORE COMPOUND |
| CN104254322B (zh) | 2012-02-15 | 2017-06-13 | 武田药品工业株式会社 | 片剂 |
| US9238639B2 (en) | 2012-02-24 | 2016-01-19 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| CA2868713A1 (en) | 2012-03-29 | 2013-10-03 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| EP2848622A4 (en) | 2012-05-10 | 2015-11-04 | Takeda Pharmaceutical | AROMATIC RING CONNECTION |
| EP2848621A4 (en) | 2012-05-10 | 2016-06-01 | Takeda Pharmaceutical | AROMATIC CYCLIC COMPOUND |
| JP6122879B2 (ja) | 2012-06-05 | 2017-04-26 | 武田薬品工業株式会社 | 固形製剤 |
| US9630976B2 (en) | 2012-07-03 | 2017-04-25 | Ono Pharmaceutical Co., Ltd. | Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
| JP2015127299A (ja) | 2012-07-19 | 2015-07-09 | 武田薬品工業株式会社 | 固形製剤 |
| WO2014142363A1 (en) | 2013-03-14 | 2014-09-18 | Takeda Pharmaceutical Company Limited | Spiro azetidine isoxazole derivatives and their use as sstr5 antagonists |
| WO2014165816A1 (en) | 2013-04-05 | 2014-10-09 | North Carolina Central University | Compounds useful for the treatment of metabolic disorders and synthesis of the same |
| KR20160003128A (ko) | 2013-04-30 | 2016-01-08 | 애브비 인코포레이티드 | 아트라센탄을 사용하는 지질 프로파일을 개선시키기 위한 방법 |
| AR096848A1 (es) | 2013-07-09 | 2016-02-03 | Takeda Pharmaceuticals Co | Derivados de indazol con actividad antagonista del receptor de la hormona concentradora de melanina (mch) |
| JP6397410B2 (ja) | 2013-08-09 | 2018-09-26 | 武田薬品工業株式会社 | 芳香環化合物 |
| KR20160062023A (ko) | 2013-09-30 | 2016-06-01 | 오노 야꾸힝 고교 가부시키가이샤 | 소마토스타틴 수용체 작동 활성을 갖는 화합물 및 그 의약 용도 |
| JO3442B1 (ar) | 2013-10-07 | 2019-10-20 | Takeda Pharmaceuticals Co | مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5) |
| US9346776B2 (en) | 2014-02-13 | 2016-05-24 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| US9428470B2 (en) | 2014-02-13 | 2016-08-30 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| US20200000816A1 (en) | 2017-02-08 | 2020-01-02 | Ono Pharmaceutical Co., Ltd. | Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof |
| JOP20180028A1 (ar) | 2017-03-31 | 2019-01-30 | Takeda Pharmaceuticals Co | مركب ببتيد |
| AR111199A1 (es) | 2017-03-31 | 2019-06-12 | Takeda Pharmaceuticals Co | Compuesto aromático agonista de gpr40 |
| JPWO2018181847A1 (ja) | 2017-03-31 | 2020-03-05 | 武田薬品工業株式会社 | 芳香環化合物 |
| IL277495B1 (en) | 2018-03-23 | 2024-04-01 | Carmot Therapeutics Inc | Modulators of protein-coupled receptors - G |
| EP3650440A4 (en) | 2018-08-27 | 2020-11-25 | Scohia Pharma, Inc. | BENZOIC ESTER COMPOUND |
| WO2020067575A1 (en) | 2018-09-24 | 2020-04-02 | Takeda Pharmaceutical Company Limited | Gip receptor agonist peptide compounds and uses thereof |
| EP3856768A2 (en) | 2018-09-24 | 2021-08-04 | Takeda Pharmaceutical Company Limited | Gip receptor agonist peptide compounds and uses thereof |
| MX2022011816A (es) | 2020-03-25 | 2022-10-10 | Takeda Pharmaceuticals Co | Dosificacion qd de compuestos peptidicos agonistas del receptor de gip y sus usos. |
| AR121649A1 (es) | 2020-03-25 | 2022-06-22 | Takeda Pharmaceuticals Co | Dosificación qw de compuestos peptídicos agonistas del receptor de gip y sus usos |
| KR20240007251A (ko) | 2021-05-13 | 2024-01-16 | 카모트 테라퓨틱스, 인크. | G-단백질 결합 수용체의 조절제 |
| WO2023169456A1 (en) | 2022-03-09 | 2023-09-14 | Gasherbrum Bio , Inc. | Heterocyclic glp-1 agonists |
| WO2023179542A1 (en) | 2022-03-21 | 2023-09-28 | Gasherbrum Bio , Inc. | 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes |
| WO2023198140A1 (en) | 2022-04-14 | 2023-10-19 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG48855A1 (en) * | 1992-04-20 | 1998-05-18 | Takeda Chemical Industries Ltd | 4,1-benzoxazepin derivatives and their use |
| AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
| AU1589895A (en) * | 1994-02-09 | 1995-08-29 | Takeda Chemical Industries Ltd. | Optically active 4,1-benzoxazepine derivatives useful as squalene synthase inhibitors |
| TW401301B (en) * | 1994-10-07 | 2000-08-11 | Takeda Chemical Industries Ltd | Antihypertriglyceridemic composition |
| EP0710725A1 (en) * | 1994-11-01 | 1996-05-08 | Takeda Chemical Industries, Ltd. | Production of optically active compounds |
-
1996
- 1996-09-12 WO PCT/JP1996/002596 patent/WO1997010224A1/en active IP Right Grant
- 1996-09-12 CN CN96196892A patent/CN1072649C/zh not_active Expired - Fee Related
- 1996-09-12 EP EP96930365A patent/EP0862562B1/en not_active Expired - Lifetime
- 1996-09-12 AU AU69442/96A patent/AU6944296A/en not_active Abandoned
-
1997
- 1997-03-12 ZA ZA972134A patent/ZA972134B/xx unknown
-
2001
- 2001-09-26 GR GR20010401564T patent/GR3036707T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0862562B1 (en) | 2001-07-04 |
| AU6944296A (en) | 1997-04-01 |
| CN1072649C (zh) | 2001-10-10 |
| EP0862562A1 (en) | 1998-09-09 |
| CN1196052A (zh) | 1998-10-14 |
| WO1997010224A1 (en) | 1997-03-20 |
| ZA972134B (en) | 1999-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3036707T3 (en) | Benzoxazepine compounds, their production and use as lipid lowering agents | |
| HU9603495D0 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents | |
| GB2304832B (en) | Porous-plastic bearing | |
| HU9600732D0 (en) | Cyclic compounds, their production and use | |
| EP0731121A3 (de) | Aminomodifizierte Urethanacrylate | |
| HU9600255D0 (en) | New compounds | |
| DE69628446D1 (en) | Polycarbonatharz, vernetztes polycarbonatharz und elektrophotographischer photorezeptor | |
| IL122987A0 (en) | Novel 2,3-dioso-1, 2, 3, 4-tetrahydro-quinoxalinyl derivatives | |
| AU1808895A (en) | Spaced fabric | |
| HUP9802807A3 (en) | 1,3,8-triazo-spiro[4,5]decan-4-on derivatives, their use, production thereof and medicaments containing the same | |
| AU6016896A (en) | Heterocyclic compounds, their production and use | |
| HUP9900506A3 (en) | Prothrombin derivatives | |
| AP9500731A0 (en) | 1,5 benzodiazepine derivatives | |
| EP0861320A4 (en) | SEQUESTRIN | |
| ZA964129B (en) | N-acyl-2-aryl cyclopropylmethylamine derivatives as melatonerigics | |
| AU2935895A (en) | Tricyclic compounds, their production and use | |
| ZA962112B (en) | New compounds | |
| AU7177496A (en) | Piperidinylethylamide derivatives as serotonergic agents | |
| AU4496896A (en) | Cephem compounds, their production and use | |
| GB2342128B (en) | Porous-plastic bearing | |
| AU691256B2 (en) | Medrogestrone production | |
| GR3035910T3 (en) | Derivatives of 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide | |
| AU5781396A (en) | Cephem compounds, their production and use | |
| GB9516561D0 (en) | Sit up | |
| ZA963484B (en) | New use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |
Effective date: 20110404 |